![](/img/cover-not-exists.png)
Sunitinib versus sorafenib as initial targeted therapy for mCC-RCC with favourable/intermediate risk: multicentre randomised trial CROSS-J-RCC
Tomita, Yoshihiko, Naito, Sei, Sassa, Naoto, Takahashi, Atsushi, Kondo, Tsunenori, Koie, Takuya, Obara, Wataru, Kobayashi, Yasuyuki, Teishima, Jun, Takahashi, Masayuki, Matsuyama, Hideyasu, Ueda, TakeJournal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2020.01.001
Date:
March, 2020
File:
PDF, 902 KB
2020